Annette Veltmar, KELES expert advisor, brings over 25 years of international leadership experience to the KELES investment team. With a focus on life sciences, healthcare, and digital health, Annette plays a pivotal role in deal-flow analysis, investment decisions, and portfolio support. Her deep understanding of the German, Austrian, and Swiss markets, combined with her extensive biotech knowledge, positions her as a key contributor to KELES’ mission of driving innovation in healthcare.
Healthcare experience
As a KELES expert advisor, Annette Veltmar has a proven track record in the pharmaceutical and biotech sectors, having held senior leadership roles at renowned companies such as Deciphera Pharmaceuticals, Amgen, and AstraZeneca. In these roles, she led successful product launches, fostered sustained business growth, and spearheaded transformative strategies in rare diseases, hematology/oncology, and specialty care. Her ability to identify opportunities and navigate challenges in these specialized fields highlights her exceptional strategic vision and operational excellence.
Other accomplishments
Moreover, Annette’s decade-long tenure at The Boston Consulting Group as a senior member of the global healthcare practice enriched her expertise in developing impactful strategies for top-tier life sciences companies. Currently, she advises private equity and venture capital firms, leveraging her insights to shape healthcare investment strategies.
Transitioning seamlessly between operational and strategic leadership, Annette excels at building organizations, securing market access for innovative therapies, and guiding teams through complex change management processes. Therefore, her scientific rigor paired with her business acumen, makes her an invaluable asset to KELES as it strengthens its investment portfolio and solidifies its leadership in digital health innovation.
In conclusion, Annette Veltmar brings a unique combination of experience, knowledge, and vision to the team. Her role is critical in supporting KELES’ goal to deliver transformative growth and drive success in the rapidly evolving healthcare and digital health landscapes.